We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

The S&P 500 fell 1.1% on Wednesday, March 26, 2025, as tech stocks faltered and the White House prepared to announce tariffs ...

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been assigned an average rating of “Hold” from the twenty-four ...

Moderna (NASDAQ:MRNA – Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from $40.00 to ...

Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Moderna with a target price of $78. * In a cautious move, an analyst from Goldman Sachs downgraded its rating to Neutral ...

US stocks surged with strong gains in tech, banking, and airline sectors. Investors welcomed reports of scaled-back tariffs, fueling a bullish market mood.

U.S. stocks turned in a fine performance on Monday, with the technology sector posting more pronounced gains. The market stayed positive as the mood remained bullish right ...

The second group, so-called "Constrained Losers," are those hard-to-short stocks that have lost the most over the trailing year. The professors found that these stocks also lag the market, but for a ...

With the post-election bump erased from stocks, souring sentiment has been especially pronounced among hedge funds. Fund managers net sold US equities for 10 of the last 11 weeks, which pushed the US ...